Share of Eli Lilly (LLY) and Novo Nordisk (NVO) are down 3% afterhours on the comments.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on LLY:
- Eli Lilly and Cipla’s Diabetes Study: A Market Game Changer?
- Eli Lilly’s Latest Study on Obesity Treatment: A Promising Update
- Novo Nordisk (NVO) Starts Cutting Jobs in the United States
- Nektar litigation hearing against Lilly delayed, says B. Riley
- Eli Lilly announces orforglipron met primary endpoint in ACHIEVE-2, ACHIEVE-5